Abridge has been named to the Forbes Al 50 List for the third year in a row.

The list spotlights the most promising privately-held Al companies in the world, including Anthropic, OpenAl, and Harvey.

This recognition highlights what it takes to deliver Al at scale in healthcare: deep health system partnerships, rigorous technology, and sustained focus on one of the most complex and consequential moments in medicine, the clinical conversation.

Today, Abridge is trusted by more than 250 of the largest and most complex health systems in the U.S., and is projected to support more than 100 million clinical conversations this year.

Read more here

‍